(2012) Prognosis in Patients with Non-Small Cell Lung Cancer Who Received Erlotinib Treatment and Subsequent Dose Reduction due to Skin Rash. Onkologie 35 , 747-752 /Takashima N, Kimura T, Watanabe N, et al. Prognosis in patients with non-small cell lung cancer who received erlotinib ...
FoxM1 Is Associated with Poor Prognosis of Non-Small Cell Lung Cancer Patients through Promoting Tumor Metastasis FoxM1 has been reported to be important in initiation and progression of various tumors. However, whether FoxM1 has any indication for prognosis in non-sma... N Xu,D Jia,W Chen,...
Khalvati, Radiomics-based prognosis analysis for non-small cell lung Cancer, Sci. ... Y Zhang,A Oikonomou,A Wong,... - 《Scientific Reports》 被引量: 0发表: 2017年 Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing ...
For more advanced cancers, functional status has consistently demonstrated an association with survival, although length of survival may depend on the underlying cancer. For example, for patients with metastatic cancer with relatively good treatment options, such as prostate or breast cancer, prognosis ...
In cancer prediction, we validated the clinical value of synthetic PET in prediction of the development of lung cancer and in staging prediction. In staging prediction, two radiologists assess the synthetic PET capability for accurately staging the lung cancer patients. In the subsection “synthetic ...
(P<0.003) or squamous cell carcinoma (P=0.023) in the TCGA data set. We validate the survival prediction framework with the TMA cohort (P<0.036 for both tumour types). Our results suggest that automatically derived image features can predict the prognosis of lung cancer patients and thereby ...
The invention provides methods for identifying early stage non-small cell lung cancer (NSCLC) patients who will have a favorable prognosis for the recurrence of lung cancer after surgical resection. The invention is based on the discovery that assessment of chromosomal copy number abnormalities at two...
Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathologi- cal stage I non-small cell lung cancer. Eur J Cardiothorac Surg ... Katsunari,Matsuoka,Shinichi,... - European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thora...
The aim of this study is to investigate the clinical value and potential prognostic significance of lung function assessment and Testin expression in non-small cell lung cancer (NSCLC) patients. Methods The NSCLC patients were classified into three groups according to lung function: group of normal...
The aim of our study was the comparative evaluation of a relative survival model and a Cox model to determine the prognostic factors of survival for patients with surgically cured non-small cell lung cancer (NSCLC). We focused particularly on the exact role of age in this survival. 156 ...